Bladder Neoplasm — Trials

Bladder Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,701 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 301–350 of 537 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04876313	An Open Label, Single-arm, Phase 2 Study of Neoadjuvant Nivolumab and Nab-paclitaxel Before Radical Cystectomy for Patients With Muscle-invasive Bladder Cancer (NURE-Combo)(NURE-Combo)	unknown	Phase 2	29	IRCCS San RaffaeleOTHER	1	Apr 6, 2022	clinicaltrials
NCT03836352	Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors	active not recruiting	Phase 2	184	ImmunoVaccine Technologies, Inc. (IMV Inc.)